prikaz prve stranice dokumenta Kanabis u liječenju karcinomske boli
  Download
PDF 91.64 KB
Scientific paper - Review paper
Kanabis u liječenju karcinomske boli
Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, 73 (2019), Suplement 1; 65-69. urn:nbn:hr:184:611071
Lončarić Katušin, Mirjana; Arbanas, Dahna; Žilić, Antonio; Jančić, Ervin; Žunić, Josip

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Lončarić Katušin, M., Arbanas, D., Žilić, A., Jančić, E. & Žunić, J. (2019). Kanabis u liječenju karcinomske boli. Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, 73. (Suplement 1), 65-69. Retrieved from https://urn.nsk.hr/urn:nbn:hr:184:611071

Lončarić Katušin, Mirjana, et al. "Kanabis u liječenju karcinomske boli." Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, vol. 73, no. Suplement 1, 2019, pp. 65-69. https://urn.nsk.hr/urn:nbn:hr:184:611071

Lončarić Katušin, Mirjana, Dahna Arbanas, Antonio Žilić, Ervin Jančić and Josip Žunić. "Kanabis u liječenju karcinomske boli." Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske 73, no. Suplement 1 (2019): 65-69. https://urn.nsk.hr/urn:nbn:hr:184:611071

Lončarić Katušin, M., et al. (2019) 'Kanabis u liječenju karcinomske boli', Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, 73(Suplement 1), pp. 65-69. Available at: https://urn.nsk.hr/urn:nbn:hr:184:611071 (Accessed 04 December 2024)

Lončarić Katušin M, Arbanas D, Žilić A, Jančić E, Žunić J. Kanabis u liječenju karcinomske boli. Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske [Internet]. 2019 [cited 2024 December 04];73(Suplement 1):65-69. Available at: https://urn.nsk.hr/urn:nbn:hr:184:611071

M. Lončarić Katušin, D. Arbanas, A. Žilić, E. Jančić and J. Žunić, "Kanabis u liječenju karcinomske boli", Acta medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske, vol. 73, no. Suplement 1, pp. 65-69, 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:611071. [Accessed: 04 December 2024]

Metadata
Title (croatian)Kanabis u liječenju karcinomske boli
Title (english)Cannabis in cancer pain management
AuthorMirjana Lončarić Katušin
AuthorDahna Arbanas
AuthorAntonio Žilić
AuthorErvin Jančić
AuthorJosip Žunić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Anaesthesiology,reanimatology and Intensive Care)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (croatian)
Kanabinoidi, aktivni sastojci Cannabis sativa, oponašaju učinke endogenih kanabinoida (endokanabinoidi), aktivacijom specifičnih kanabinoidnih receptora, osobito CB1 dominantno smještenih u centralom živčanom sustavu i CB2 pretežito u stanicama uključenim u imunološku funkciju. Kanabinoidi su učinkoviti za liječenje boli kod odraslih, kemoterapijom inducirane mučnine i povraćanja i spasticiteta udruženog s multiplom sklerozom. Medicinski kanabis umanjuje kroničnu ili neuropatsku bol kod bolesnika s uznapredovalim karcinomom. Nedostatno liječenje kronične i neuropatske boli udružene s karcinomom ima negativne učinke na kvalitetu života bolesnika. Kod neuropatske boli i karcinomske boli medicinski kanabinoidi dolaze u obzir za bolesnike čije je stanje refraktorno na standardno liječenje. Medicinski kanabinoidi dodatak su drugim propisanim analgeticima. Potencijalnu štetu i korist treba razmotriti s bolesnikom.
Abstract (english)
Cannabinoids, the active components of Cannabis sativa, mimic the effects of endogenous cannabinoids (endocannabinoids), activating specifi c cannabinoid receptors, particularly CB1 found predominantly in the central nervous system and CB2 found predominantly in the cells involved in immune function. Cannabinoids are effective in the treatment of pain in adults, chemotherapy-induced nausea and vomiting and spasticity associated with multiple sclerosis. In cancer patients, cannabis has a number of potential benefi ts, especially in the management of symptoms. Medical cannabis reduces chronic or neuropathic pain in advanced cancer patients. Insuffi cient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life. In neuropathic pain and cancer pain, medical cannabinoids should only be considered for patients whose conditions are refractory to standard therapies. Medical cannabinoids are adjuncts to other prescribed analgesics. The potential harms and benefi ts should be discussed with the patient.
Keywords (croatian)
Keywords (english)
Languagecroatian
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titleActa medica Croatica : Časopis Akademije medicinskih znanosti Hrvatske
Numberingvol. 73, no. Suplement 1, pp. 65-69
p-ISSN1330-0164
e-ISSN1848-8897
URN:NBNurn:nbn:hr:184:611071
Publication2019
Document URLhttps://hrcak.srce.hr/224659
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2022-02-09 08:42:55